Invivyd, Inc.
IVVD • NASDAQ
Invivyd, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William E. Duke Jr., with a market cap of $387.2M.
CEOWilliam E. Duke Jr.
Next Earnings
Upcoming earnings announcement for Invivyd, Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.08
Revenue Estimate
$18.2M
Earnings History
Past 12 earnings reports for Invivyd, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | $0.02Est: -$0.08 | +125.0% | $17.2MEst: $15.7M | +9.3% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.06Est: -$0.08 | +25.0% | $13.1MEst: $14.3M | -8.4% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.12Est: -$0.01 | -1100.0% | $11.8MEst: $20.1M | -41.4% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.14Est: -$0.01 | -1300.0% | $11.3MEst: $34.5M | -67.2% | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.15Est: -$0.33 | +54.5% | $13.8MEst: $15.8M | -12.4% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.51Est: -$0.35 | -45.7% | $9.3MEst: $27.3M | -65.9% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.40Est: -$0.36 | -11.1% | $2.3MEst: $6.0M | -62.3% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.38Est: -$0.38 | 0.0% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.67Est: -$0.42 | -59.5% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.36Est: -$0.50 | +28.0% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.46Est: -$0.40 | -15.0% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.32Est: -$0.30 | -6.7% | - | — | — |